Systemic IgE treatment in this model was also associated with a specific cytokine signature, featuring elevated levels of TNFα, MCP-1 and IL-10 in the tumour microenvironment and upregulated expression of TNFα by tumour-associated macrophages in rat lungs. Here, CCL2 is linked to neoplasm.